Omalizumab versus Danazol in the Management of Challenging Cholinergic Urticaria

In: Journal of Allergy and Clinical Immunology · 2025 · vol. 155(2) , pp. AB199 · doi:10.1016/j.jaci.2024.12.617 · W4407338879
article OA: bronze CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-09-26 ⓘ

The provided text contains only a title and no abstract, making it impossible to summarize the study's findings or determine its relevance to endometriosis and adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-05-14T06:24:27.071974+00:00
License: CC0 · commercial use OK